India Glycols Limited FY26 Results Showcase Strong Revenue and Profit Growth

India Glycols Limited has reported a strong financial performance for the Full Year FY26, marked by an 11.8% rise in net revenue to ₹4,211 crore. The company saw a significant surge in profitability, with EBITDA increasing by 24.5% and PAT growing by 26.8% compared to the previous year. This growth was driven by consistent volume gains, strategic product mix improvements, and operational efficiencies across all business segments.

Financial Highlights

For the financial year ended March 31, 2026, India Glycols Limited demonstrated robust operational strength. The company achieved a net revenue of ₹4,211 crore, representing an 11.8% increase over FY25. Profitability metrics also saw significant improvement, with EBITDA reaching ₹654 crore, up 24.5%, and PAT standing at ₹293 crore, reflecting a 26.8% year-on-year growth. Cash generation from operations was particularly strong, surging to ₹769 crore, a 112.4% increase compared to the prior year.

Segment Performance

The company’s diverse product portfolio contributed to its broad-based growth. The Potable Spirits segment remained a key revenue driver, delivering ₹1,331 crore in revenue with a healthy 21.4% EBIT margin, supported by successful premiumization efforts. The Bio-Fuel segment showcased exceptional growth, with revenue rising by 40.9%. Additionally, the Bio-based Specialties & Performance Chemicals (BSPC) division saw EBIT growth of 12.5%, with margins expanding to 11.7%.

Strategic Restructuring Updates

India Glycols continues to progress with its proposed demerger scheme to streamline business operations and unlock shareholder value. The company plans to separate its Potable Spirits, Bio-Fuel, and Bio-Pharma businesses into distinct entities. This strategic realignment is designed to improve management focus, allow for independent growth trajectories for each segment, and ensure more efficient capital allocation. The application for the demerger scheme has been admitted, with further hearings scheduled to move the process toward completion.

Future Outlook

Looking ahead, India Glycols remains well-positioned to capitalize on the increasing demand for sustainable, green-chemistry-derived products. By leveraging its integrated manufacturing capabilities and a robust R&D pipeline, the company plans to continue expanding its presence across global markets while maintaining its commitment to environmental and operational excellence.

Source: BSE

Previous Article

Strides Pharma Science Limited Financial Results for Year Ended March 31, 2026, and Dividend Declaration

Next Article

Tata Consumer Products Announcement of 63rd Annual General Meeting